GFM

GFM is an emerging biotechnology company focused on the development of novel therapeutic agents targeting growth factor metabolism and signaling pathways. The company utilizes a proprietary discovery platform to identify and optimize small molecules and peptides that modulate key biological drivers in oncology and metabolic diseases. GFM's lead programs are currently in the pre-clinical stage, with a focus on high-affinity binding and improved pharmacokinetic profiles. By addressing unmet medical needs through precision modulation of growth factors, GFM aims to provide next-generation treatments for complex chronic conditions.